Company Encyclopedia
View More
name
Alibaba Related
CP20004.HK
News
View More

Alibaba Health Grants 3.5 Million RSUs Under 2024 Share Award Scheme

Alibaba Health Information Technology Limited has granted 3,515,900 restricted share units (RSUs) to 50 employees as part of its 2024 Share Award Scheme. This grant was made on December 16, 2025. Following this, 1,550,493,126 shares remain available for future grants under the main scheme, with an additional 160,917,362 shares available under the service provider sublimit.

Reuters·
HK
00241
-1.53%
Reuters·
HK
00241
-1.53%

Alibaba Health Information Technology Chairman Resigns

Alibaba Health Information Technology Chairman Resigns

marketscreener·
HK
00241
-1.53%
marketscreener·
HK
00241
-1.53%

The second foreign-funded 100 billion private equity "rises": from Bridgewater's solo dance to the competition of the two giants

Tengsheng Investment has launched a new round of product fundraising in the Chinese market, becoming the second foreign private equity firm with a scale of over 10 billion yuan. This fundraising is distributed by leading brokerages such as CITIC Securities and CICC Wealth, with the product primarily based on the CSI 500 Index enhancement strategy, and a small allocation to commodity futures CTA strategies. Tengsheng Investment was established in 2018 and is a wholly foreign-owned private securities manager of Two Sigma in China, responsible for the implementation of the parent company's quantitative strategies in the Chinese market

Wallstreetcn·
SH
600030
-0.25%
HK
06030
-1.53%
SH
601995
0.00%
Wallstreetcn·
SH
600030
-0.25%
HK
06030
-1.53%
SH
601995
0.00%

Alibaba Health Announces New Board of Directors

Alibaba Health Information Technology has announced a new board of directors, effective December 15, 2025. The update details the roles and functions of each director and the composition of board committees, reflecting the company's strategic direction and governance structure. This announcement may impact operations and stakeholder relationships. The latest analyst rating for Alibaba Health stock (HK:0241) is a Sell with a HK$4.60 price target.

Tip Ranks·
HK
00241
-1.53%
Tip Ranks·
HK
00241
-1.53%

Shen Difan Appointed Chairman of Alibaba Health Information Technology

Alibaba Health Information Technology Ltd. has appointed Shen Difan as the new chairman of the board and chairman of the nomination committee, effective December 15, 2025. Shen Difan is also the CEO. Zhu Shunyan resigned from his roles as non-executive director, chairman, and chairman of the nomination committee.

Reuters·
HK
00241
-1.53%
Reuters·
HK
00241
-1.53%
Posts
View More

$XTALPI(02228.HK) Southbound Stock Connect continues to increase holdings: 1,014,029,370    Percentage: 25.22%.  At the same time, CICC Securities' holdings continue to decrease: still holding 43,985,...

  • 0

$XTALPI(02228.HK) Goldman Sachs launched the "China AI Healthcare Index" today, with Pharmaron as the top-weighted stock $ALI HEALTH(00241.HK)$JD HEALTH(06618.HK)$PA GOODDOCTOR(01833.HK)$YIDU TECH(021...

  • 0
© 2025 Longbridge｜Disclaimer